Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lanying Du

Showing results (11-20 of 182) with videos related to

Pageof 19
Sort By:
Expert Opinion on Therapeutic Targets|September 17, 2020
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2Shibo Jiang, Xiujuan Zhang, Lanying Du
Future Virology|March 24, 2020
Development of SARS vaccines and therapeutics is still neededShibo Jiang, Lu Lu, Lanying Du
Cellular & Molecular Immunology|September 9, 2021
Neutralizing antibodies for the prevention and treatment of COVID-19Lanying Du, Yang Yang, Xiujuan Zhang
Emerging Microbes & Infections|February 2, 2020
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategiesShibo Jiang, Lanying Du, Zhengli Shi
The Journal of Infection|May 21, 2013
Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMCLanying Du, Cuiqing Ma, Shibo Jiang
Trends in Immunology|April 7, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human CoronavirusesShibo Jiang, Christopher Hillyer, Lanying Du
Nature Reviews. Microbiology|October 17, 2020
Learning from the past: development of safe and effective COVID-19 vaccinesShan Su, Lanying Du, Shibo Jiang
Expert Review of Vaccines|July 31, 2018
Prospects for a MERS-CoV spike vaccineYusen Zhou, Shibo Jiang, Lanying Du
Microbes and Infection|January 19, 2010
Research and development of universal influenza vaccinesLanying Du, Yusen Zhou, Shibo Jiang
Expert Review of Vaccines|August 8, 2017
The latest advancements in Zika virus vaccine developmentLanying Du, Yusen Zhou, Shibo Jiang
Pageof 19

Showing results (11-20 of 182) with videos related to

Sort By:
Pageof 19
Expert Opinion on Therapeutic Targets|September 17, 2020
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2Shibo Jiang, Xiujuan Zhang, Lanying Du
Future Virology|March 24, 2020
Development of SARS vaccines and therapeutics is still neededShibo Jiang, Lu Lu, Lanying Du
Cellular & Molecular Immunology|September 9, 2021
Neutralizing antibodies for the prevention and treatment of COVID-19Lanying Du, Yang Yang, Xiujuan Zhang
Emerging Microbes & Infections|February 2, 2020
An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategiesShibo Jiang, Lanying Du, Zhengli Shi
The Journal of Infection|May 21, 2013
Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMCLanying Du, Cuiqing Ma, Shibo Jiang
Trends in Immunology|April 7, 2020
Neutralizing Antibodies against SARS-CoV-2 and Other Human CoronavirusesShibo Jiang, Christopher Hillyer, Lanying Du
Nature Reviews. Microbiology|October 17, 2020
Learning from the past: development of safe and effective COVID-19 vaccinesShan Su, Lanying Du, Shibo Jiang
Expert Review of Vaccines|July 31, 2018
Prospects for a MERS-CoV spike vaccineYusen Zhou, Shibo Jiang, Lanying Du
Microbes and Infection|January 19, 2010
Research and development of universal influenza vaccinesLanying Du, Yusen Zhou, Shibo Jiang
Expert Review of Vaccines|August 8, 2017
The latest advancements in Zika virus vaccine developmentLanying Du, Yusen Zhou, Shibo Jiang
Pageof 19